Amy C. Thomas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Amy C. Thomas has a total of 174 co-authors. Here are the top co-authors by number of shared publications:
- Ellen Brooks-Pollock
University of Bristol
15 shared publications Genevieve Clapp
Population Health Sciences, Bristol Medical School University of Bristol Bristol UK
7 shared publications- Leon Danon
University of Bristol
6 shared publications - Nicholas John Timpson
University of Bristol
6 shared publications - Adam Finn
University of Bristol
5 shared publications - Gibran Hemani
University of Bristol
5 shared publications
Latest Publications
- Open Access
- 6 January 2026
- Published by Wiley in Zoonoses and Public Health
- Vol. 73 (2) , 152-163
Biosecurity Uptake and Perceived Risk of Avian Influenza Among People in Contact With Birds
Introduction: Recent intercontinental spread of highly pathogenic avian influenza (HPAI) A(H5N1) among kept and wild birds, and transmission to mammalian hosts, including cattle and humans, has heightened the need to review public health risk assessments. Biosecurity measures (BMs) are essential for limiting disease spread, but how widely different practices are implemented is not fully known. Methods: Here, we report on the uptake of BMs and risk perception of avian influenza virus (AIV) in the context of preventing zoonotic transmission to persons potentially at high risk of exposure. Questionnaire data from 225 people in contact with birds in the UK (Avian Contact Study, May to July 2024) were analysed. Results: We found hand washing after contact with birds was the most common BM implemented (89%, 196 of 218), followed by using disinfecting footwear dips (78%, 170 of 218). Individuals in contact with a higher number of birds were more likely to use at least one personal protective equipment (PPE) measure for the face or body or at least one footwear‐related PPE measure. Perceived risk of AIV to bird health was high for individuals in contact with large flocks (≥ 1001 birds) and associated with uptake of at least one footwear‐related PPE measure (independent of flock size). Perceived risk of AIV to respondents' own health was low, regardless of the number of birds a respondent had daily contact with. Conclusions: Our results indicate that routinely used BMs are implemented to limit AIV spread among birds, but not with the purpose of limiting zoonotic transmission from birds to humans. Identifying cohort characteristics which could lead to low BM uptake, alongside barriers and facilitators to BM uptake, is important for informing zoonotic AIV public health campaigns.
- 6 January 2026
- Published by Wiley in Zoonoses and Public Health
- Vol. 73 (2) , 152-163
Open AccessBiosecurity Uptake and Perceived Risk of Avian Influenza Among People in Contact With Birds
Introduction: Recent intercontinental spread of highly pathogenic avian influenza (HPAI) A(H5N1) among kept and wild birds, and transmission to mammalian hosts, including cattle and humans, has heightened the need to review public health risk assessments. Biosecurity measures (BMs) are essential for limiting disease spread, but how widely different practices are implemented is not fully known. Methods: Here, we report on the uptake of BMs and risk perception of avian influenza virus (AIV) in the context of preventing zoonotic transmission to persons potentially at high risk of exposure. Questionnaire data from 225 people in contact with birds in the UK (Avian Contact Study, May to July 2024) were analysed. Results: We found hand washing after contact with birds was the most common BM implemented (89%, 196 of 218), followed by using disinfecting footwear dips (78%, 170 of 218). Individuals in contact with a higher number of birds were more likely to use at least one personal protective equipment (PPE) measure for the face or body or at least one footwear‐related PPE measure. Perceived risk of AIV to bird health was high for individuals in contact with large flocks (≥ 1001 birds) and associated with uptake of at least one footwear‐related PPE measure (independent of flock size). Perceived risk of AIV to respondents' own health was low, regardless of the number of birds a respondent had daily contact with. Conclusions: Our results indicate that routinely used BMs are implemented to limit AIV spread among birds, but not with the purpose of limiting zoonotic transmission from birds to humans. Identifying cohort characteristics which could lead to low BM uptake, alongside barriers and facilitators to BM uptake, is important for informing zoonotic AIV public health campaigns.
- Open Access
An immunity-driven modelling framework for epidemics of non-sterilising infections
Protecting populations against infections with non-sterilising immunity, such as COVID-19 and influenza, presents a major public health challenge. Population models used to guide public health and vaccination strategies are often incompatible with individual-level immunological and virological data. To address this gap, we develop a novel and flexible mathematical framework that links within-host immune and viral dynamics to between-host transmission, bridging multiple scales from individuals to populations. Our approach derives infectiousness from viral load and protection against reinfection from time-varying levels of immune factors, allowing population-level epidemiological trajectories to emerge as the summation of individual infectiousness and immunity. As an example, we use a phenomenological model of viral load quantified in a SARS-CoV-2 human challenge study, and a mechanistic model of binding antibody levels, fit to cross-sectional SARS-CoV-2-specific binding antibody levels post-vaccination. We demonstrate the ability of this framework to go beyond conventional compartmental models by predicting times to reinfection and the number of infections experienced by individuals. As a result, we show that immune responses fundamentally shape epidemic dynamics. Low correlations between antibody levels and protection lead to frequent reinfections and endemic circulation, whereas high correlations produce recurrent and explosive outbreaks. To demonstrate the potential of this modelling approach to estimate the protective power and reinfection dynamics across diverse immune histories, we recover the model parameters by fitting to simulated case data. This interdisciplinary approach provides new insights into the drivers of irregular epidemic patterns and can inform vaccination strategies for pathogens with non-sterilising immunity.
Open AccessAn immunity-driven modelling framework for epidemics of non-sterilising infections
Protecting populations against infections with non-sterilising immunity, such as COVID-19 and influenza, presents a major public health challenge. Population models used to guide public health and vaccination strategies are often incompatible with individual-level immunological and virological data. To address this gap, we develop a novel and flexible mathematical framework that links within-host immune and viral dynamics to between-host transmission, bridging multiple scales from individuals to populations. Our approach derives infectiousness from viral load and protection against reinfection from time-varying levels of immune factors, allowing population-level epidemiological trajectories to emerge as the summation of individual infectiousness and immunity. As an example, we use a phenomenological model of viral load quantified in a SARS-CoV-2 human challenge study, and a mechanistic model of binding antibody levels, fit to cross-sectional SARS-CoV-2-specific binding antibody levels post-vaccination. We demonstrate the ability of this framework to go beyond conventional compartmental models by predicting times to reinfection and the number of infections experienced by individuals. As a result, we show that immune responses fundamentally shape epidemic dynamics. Low correlations between antibody levels and protection lead to frequent reinfections and endemic circulation, whereas high correlations produce recurrent and explosive outbreaks. To demonstrate the potential of this modelling approach to estimate the protective power and reinfection dynamics across diverse immune histories, we recover the model parameters by fitting to simulated case data. This interdisciplinary approach provides new insights into the drivers of irregular epidemic patterns and can inform vaccination strategies for pathogens with non-sterilising immunity.
- Open Access
Quantifying H5N1 outbreak potential and control effectiveness in high-risk agricultural populations
Avian influenza is a global public health threat. Since 2021, the ongoing H5N1 panzootic has brought a major shift in H5Nx epidemiology, including unprecedented spread, wide host range and lack of seasonality. Infections in marine mammals, wildlife and livestock have heightened concern for human-to-human transmission and pandemic potential. Contact tracing and self-isolation are used as public health measures in the UK to manage contacts of confirmed human cases of avian influenza. In this study, we aimed to estimate potential outbreak sizes and evaluate the effectiveness of contact tracing and self-isolation in managing community outbreaks of H5N1 following spillover from birds to people. We characterised contact patterns from an underrepresented agricultural population at high risk of avian influenza exposure through contact with birds (Avian Contact Study). Informed by these realistic social contact data, we modelled outbreak sizes using a stochastic branching process model. Most simulations resulted in small-scale outbreaks, ranging from 0 to 10 cases. When the basic reproduction number was 1.1, contact tracing and self-isolation reduced the average outbreak size from 41 cases (95% Confidence Interval (CI): 37-46 cases) to 7 cases (95% CI: 6- 8 cases), preventing, on average, 8 out of every 10 infections. However, controls became less effective in reducing the outbreak size when a higher proportion of cases were asymptomatic. Overall, our findings suggest that contact tracing and self-isolation can be effective at preventing zoonotic infections. Increasing awareness, encouraging self-isolation, and detecting asymptomatic cases through routine surveillance are important components of zoonotic infection containment strategies.
Open AccessQuantifying H5N1 outbreak potential and control effectiveness in high-risk agricultural populations
Avian influenza is a global public health threat. Since 2021, the ongoing H5N1 panzootic has brought a major shift in H5Nx epidemiology, including unprecedented spread, wide host range and lack of seasonality. Infections in marine mammals, wildlife and livestock have heightened concern for human-to-human transmission and pandemic potential. Contact tracing and self-isolation are used as public health measures in the UK to manage contacts of confirmed human cases of avian influenza. In this study, we aimed to estimate potential outbreak sizes and evaluate the effectiveness of contact tracing and self-isolation in managing community outbreaks of H5N1 following spillover from birds to people. We characterised contact patterns from an underrepresented agricultural population at high risk of avian influenza exposure through contact with birds (Avian Contact Study). Informed by these realistic social contact data, we modelled outbreak sizes using a stochastic branching process model. Most simulations resulted in small-scale outbreaks, ranging from 0 to 10 cases. When the basic reproduction number was 1.1, contact tracing and self-isolation reduced the average outbreak size from 41 cases (95% Confidence Interval (CI): 37-46 cases) to 7 cases (95% CI: 6- 8 cases), preventing, on average, 8 out of every 10 infections. However, controls became less effective in reducing the outbreak size when a higher proportion of cases were asymptomatic. Overall, our findings suggest that contact tracing and self-isolation can be effective at preventing zoonotic infections. Increasing awareness, encouraging self-isolation, and detecting asymptomatic cases through routine surveillance are important components of zoonotic infection containment strategies.
- Open Access
Biosecurity uptake and perceived risk of avian influenza among people in contact with birds
Introduction: Recent intercontinental spread of highly pathogenic avian influenza (HPAI) A(H5N1) among kept and wild birds, and transmission to mammalian hosts, including cattle and humans, has heightened the need to review public health risk assessments. Biosecurity measures (BMs) are essential for limiting disease spread, but how widely different practices are implemented is not fully known. Methods: Here, we report on the uptake of BMs and risk perception of avian influenza virus (AIV) in the context of preventing zoonotic transmission to persons potentially at high risk of exposure. Questionnaire data from 225 people in contact with birds in the UK (Avian Contact Study, May to July 2024) were analysed. Results: We found hand washing after contact with birds was the most common BM implemented (89%, 196 of 218), followed by using disinfecting footwear dips (78%, 170 of 218). Individuals in contact with a higher number of birds were more likely to use at least one personal protective equipment (PPE) measure for the face or body or at least one footwear- related PPE measure. Perceived risk of AIV to bird health was high for individuals in contact with large flocks (≥1001 birds) and associated with uptake of at least one footwear-related PPE measure (independent of flock size). Perceived risk of AIV to respondents’ own health was low, regardless of the number of birds a respondent had daily contact with. Conclusions: Our results indicate that routinely used BMs are implemented to limit AIV spread among birds, but not with the purpose of limiting zoonotic transmission from birds to humans. Identifying cohort characteristics which could lead to low BM uptake, alongside barriers and facilitators to BM uptake is important for informing zoonotic AIV public health campaigns.
Open AccessBiosecurity uptake and perceived risk of avian influenza among people in contact with birds
Introduction: Recent intercontinental spread of highly pathogenic avian influenza (HPAI) A(H5N1) among kept and wild birds, and transmission to mammalian hosts, including cattle and humans, has heightened the need to review public health risk assessments. Biosecurity measures (BMs) are essential for limiting disease spread, but how widely different practices are implemented is not fully known. Methods: Here, we report on the uptake of BMs and risk perception of avian influenza virus (AIV) in the context of preventing zoonotic transmission to persons potentially at high risk of exposure. Questionnaire data from 225 people in contact with birds in the UK (Avian Contact Study, May to July 2024) were analysed. Results: We found hand washing after contact with birds was the most common BM implemented (89%, 196 of 218), followed by using disinfecting footwear dips (78%, 170 of 218). Individuals in contact with a higher number of birds were more likely to use at least one personal protective equipment (PPE) measure for the face or body or at least one footwear- related PPE measure. Perceived risk of AIV to bird health was high for individuals in contact with large flocks (≥1001 birds) and associated with uptake of at least one footwear-related PPE measure (independent of flock size). Perceived risk of AIV to respondents’ own health was low, regardless of the number of birds a respondent had daily contact with. Conclusions: Our results indicate that routinely used BMs are implemented to limit AIV spread among birds, but not with the purpose of limiting zoonotic transmission from birds to humans. Identifying cohort characteristics which could lead to low BM uptake, alongside barriers and facilitators to BM uptake is important for informing zoonotic AIV public health campaigns.
- Open Access
- 19 April 2025
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 19 (4) , e70101
Seasonal Influenza Vaccination in People who Have Contact With Birds
Background: Following the 2021–2022 avian influenza panzootic in birds and wildlife, seasonal influenza vaccines have been advised to occupationally high‐risk groups to reduce the likelihood of coincidental infection in humans with both seasonal and avian influenza A viruses.Methods: We developed and launched a questionnaire aimed at poultry workers and people in direct contact with birds to understand awareness and uptake of seasonal influenza vaccination. We collected responses in‐person at an agricultural trade event and online.Findings: The questionnaire was completed by 225 individuals from across the United Kingdom. The most commonly reported reason for vaccination was protection against seasonal influenza (82%, 63 of 77). Nearly, all individuals aged ≥65 years reported that the vaccine was recommended for them (24 of 28). There was no difference in recommendation for occupational groups. Most vaccinees were aged over 60 years (60%, 29 of 48); however, coverage was lower than expected in the ≥ 65 target group. Vaccination in those exposed to avian influenza was low (32%, 9 of 28). Not having enough time was the single most reported reason for not getting vaccinated in those intending to. Individuals unintending to be vaccinated perceived natural immunity to be better than receiving the vaccine as well as lack of awareness and time.Conclusions: Our findings suggest that targeted campaigns in occupationally exposed groups need to be undertaken to improve communication of information and access to vaccine clinics. We recommend co‐production methods to optimise this public health strategy for increased knowledge and future vaccine uptake.
- 19 April 2025
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 19 (4) , e70101
Open AccessSeasonal Influenza Vaccination in People who Have Contact With Birds
Background: Following the 2021–2022 avian influenza panzootic in birds and wildlife, seasonal influenza vaccines have been advised to occupationally high‐risk groups to reduce the likelihood of coincidental infection in humans with both seasonal and avian influenza A viruses.Methods: We developed and launched a questionnaire aimed at poultry workers and people in direct contact with birds to understand awareness and uptake of seasonal influenza vaccination. We collected responses in‐person at an agricultural trade event and online.Findings: The questionnaire was completed by 225 individuals from across the United Kingdom. The most commonly reported reason for vaccination was protection against seasonal influenza (82%, 63 of 77). Nearly, all individuals aged ≥65 years reported that the vaccine was recommended for them (24 of 28). There was no difference in recommendation for occupational groups. Most vaccinees were aged over 60 years (60%, 29 of 48); however, coverage was lower than expected in the ≥ 65 target group. Vaccination in those exposed to avian influenza was low (32%, 9 of 28). Not having enough time was the single most reported reason for not getting vaccinated in those intending to. Individuals unintending to be vaccinated perceived natural immunity to be better than receiving the vaccine as well as lack of awareness and time.Conclusions: Our findings suggest that targeted campaigns in occupationally exposed groups need to be undertaken to improve communication of information and access to vaccine clinics. We recommend co‐production methods to optimise this public health strategy for increased knowledge and future vaccine uptake.
- Open Access
- 24 February 2025
- Vol. 9, 604
Data note on the Avian Contact Study: a questionnaire resource for avian influenza public health planning.
The Avian Contact Study is a cross-sectional questionnaire of poultry workers and other individuals who have contact with domestic and/or wild birds in the UK. The questionnaire was launched online in May 2024 and in-person responses were gathered at the British Pig and Poultry Fair in Birmingham on 15 and 16 May 2024. This Data Note documents questionnaire development, content and delivery methods. Data collected include information on demographics, seasonal influenza vaccination, avian influenza exposure, contact with birds and people, and awareness of avian influenza. This Data Note provides insights into the first data release collected up to 31 July 2024 for 225 respondents. Data have been released as a University of Bristol held dataset available upon request. The Avian Contact Study provides a pilot resource for research into avian influenza from a zoonotic perspective.
- 24 February 2025
- Vol. 9, 604
Open AccessData note on the Avian Contact Study: a questionnaire resource for avian influenza public health planning.
The Avian Contact Study is a cross-sectional questionnaire of poultry workers and other individuals who have contact with domestic and/or wild birds in the UK. The questionnaire was launched online in May 2024 and in-person responses were gathered at the British Pig and Poultry Fair in Birmingham on 15 and 16 May 2024. This Data Note documents questionnaire development, content and delivery methods. Data collected include information on demographics, seasonal influenza vaccination, avian influenza exposure, contact with birds and people, and awareness of avian influenza. This Data Note provides insights into the first data release collected up to 31 July 2024 for 225 respondents. Data have been released as a University of Bristol held dataset available upon request. The Avian Contact Study provides a pilot resource for research into avian influenza from a zoonotic perspective.
- Open Access
Seasonal influenza vaccination in people who have contact with birds
Background: Following the 2021-2022 avian influenza panzootic in birds and wildlife, seasonal influenza vaccines have been advised to occupationally high-risk groups to reduce the likelihood of coincidental infection in humans with both seasonal and avian influenza A viruses. Methods: We developed and launched a questionnaire aimed at poultry workers and people in direct contact with birds to understand awareness and uptake of seasonal influenza vaccination. We collected responses in-person at an agricultural trade event and online. Findings: The questionnaire was completed by 225 individuals from across the UK. The most commonly reported reason for vaccination was protection against seasonal influenza (82%, 63 of 77). Nearly all individuals aged ≥65 years reported that the vaccine was recommended for them (24 of 28). There was no difference in recommendation for occupational groups. Most vaccinees were aged over 60 years (60%, 29 of 48), however coverage was lower than expected in the ≥65 target group. Vaccination in those exposed to avian influenza was low (32%, 9 of 28). Not having enough time was the single most reported reason for not getting vaccinated in those intending to. Individuals unintending to be vaccinated perceived natural immunity to be better than receiving the vaccine as well as lack of awareness and time. Conclusions: Our findings suggest that targeted campaigns in occupationally exposed groups need to be undertaken to improve communication of information and access to vaccine clinics. We recommend co-production methods to optimise this public health strategy for increased knowledge and future vaccine uptake.
Open AccessSeasonal influenza vaccination in people who have contact with birds
Background: Following the 2021-2022 avian influenza panzootic in birds and wildlife, seasonal influenza vaccines have been advised to occupationally high-risk groups to reduce the likelihood of coincidental infection in humans with both seasonal and avian influenza A viruses. Methods: We developed and launched a questionnaire aimed at poultry workers and people in direct contact with birds to understand awareness and uptake of seasonal influenza vaccination. We collected responses in-person at an agricultural trade event and online. Findings: The questionnaire was completed by 225 individuals from across the UK. The most commonly reported reason for vaccination was protection against seasonal influenza (82%, 63 of 77). Nearly all individuals aged ≥65 years reported that the vaccine was recommended for them (24 of 28). There was no difference in recommendation for occupational groups. Most vaccinees were aged over 60 years (60%, 29 of 48), however coverage was lower than expected in the ≥65 target group. Vaccination in those exposed to avian influenza was low (32%, 9 of 28). Not having enough time was the single most reported reason for not getting vaccinated in those intending to. Individuals unintending to be vaccinated perceived natural immunity to be better than receiving the vaccine as well as lack of awareness and time. Conclusions: Our findings suggest that targeted campaigns in occupationally exposed groups need to be undertaken to improve communication of information and access to vaccine clinics. We recommend co-production methods to optimise this public health strategy for increased knowledge and future vaccine uptake.
- Open Access
High Mycobacterium bovis exposure but low IGRA positivity in UK farm workers
Background: Between 1999 and 2021, 505 culture-confirmed cases of M. bovis disease in humans (zoonotic tuberculosis, TB) were identified in England. We aimed to estimate the prevalence of M. bovis infection in persons exposed to TB-infected cattle in England and identify any risk factors associated with latent TB infection (LTBI) in this population. Methods: We co-developed a retrospective cohort study in southwest England, a bovine TB high risk area, with members of the UK farming community. A questionnaire captured participant characteristics, behaviours and farming practices. Linkage with historical herd testing data was used to categorise participants as low, medium or high risk for TB exposure. Interferon gamma release assay (IGRA) positivity with Quantiferon was used to determine LTBI status and linked to questionnaire data. Results: We recruited 90 participants at agricultural shows and a standalone event. Participants were farmers/farm workers (79/90) and veterinary professionals (11/90). Median age was 45.5 years (IQR: 19–77); 58% were male; 66% reported BCG vaccination. M. bovis exposure was via direct contact with infected cattle and consumption of raw milk. One participant in the high-risk group was IGRA positive, all other participants were IGRA negative. Estimated IGRA positivity rate was 1.1% (95% CI 0.058%–7.0%) in all participants and 4.0% (95%CI 0.21%–22%) in participants with high exposure levels. Conclusions: We found limited LTBI in individuals in contact with TB-infected cattle in England, despite high and prolonged exposure. We identified a high-risk group of farmers who should be prioritised for future engagement.
Open AccessHigh Mycobacterium bovis exposure but low IGRA positivity in UK farm workers
Background: Between 1999 and 2021, 505 culture-confirmed cases of M. bovis disease in humans (zoonotic tuberculosis, TB) were identified in England. We aimed to estimate the prevalence of M. bovis infection in persons exposed to TB-infected cattle in England and identify any risk factors associated with latent TB infection (LTBI) in this population. Methods: We co-developed a retrospective cohort study in southwest England, a bovine TB high risk area, with members of the UK farming community. A questionnaire captured participant characteristics, behaviours and farming practices. Linkage with historical herd testing data was used to categorise participants as low, medium or high risk for TB exposure. Interferon gamma release assay (IGRA) positivity with Quantiferon was used to determine LTBI status and linked to questionnaire data. Results: We recruited 90 participants at agricultural shows and a standalone event. Participants were farmers/farm workers (79/90) and veterinary professionals (11/90). Median age was 45.5 years (IQR: 19–77); 58% were male; 66% reported BCG vaccination. M. bovis exposure was via direct contact with infected cattle and consumption of raw milk. One participant in the high-risk group was IGRA positive, all other participants were IGRA negative. Estimated IGRA positivity rate was 1.1% (95% CI 0.058%–7.0%) in all participants and 4.0% (95%CI 0.21%–22%) in participants with high exposure levels. Conclusions: We found limited LTBI in individuals in contact with TB-infected cattle in England, despite high and prolonged exposure. We identified a high-risk group of farmers who should be prioritised for future engagement.
- Open Access
Mechanistic models of humoral kinetics following COVID-19 vaccination
Introduction: Future COVID-19 vaccine programmes need to take into account the variable responses elicited by different vaccines and their waning protection over time. Existing descriptions of antibody response to COVID-19 vaccination convey limited information about the mechanisms of antibody production and maintenance. Methods: We describe the antibody dynamics elicited by COVID-19 vaccination with two biologically-motivated mathematical models of antibody production by plasma cells and subsequent decay. We fit the models using Markov Chain Monte Carlo to seroprevalence data from 14,602 uninfected individuals collected via the primary care network in England between May 2020 and September 2022. We ensure our models are structurally and practically identifiable when using antibody data alone. We analyse the effect of age, vaccine type, number of doses, and the interval between doses on antibody production and longevity of response. Results: We find evidence that individuals over 35 years of age who received a second dose of ChAdOx1-S generate a persistent antibody response suggestive of long-lived plasma cell induction, while individuals that receive two doses of BNT162b2, or one dose of either vaccine do not. We also find that plasamblast productive capacity, the likely driver of short-term antibody responses, is greater in younger people than older people (≤ 4.5 fold change in point estimates), people vaccinated with two doses than people vaccinated with one dose (≤ 12 fold change), and people vaccinated with BNT162b2 than people vaccinated with ChAdOx1-S (≤ 440 fold change). The effect of age on antibody dynamics is more pronounced in people vaccinated with BNT162b2 than people vaccinated with ChAdOx1-S. We find the half-life of an antibody to be between 23 – 106 days. Conclusion: Routinely-collected seroprevalence data are a valuable source of information for characterising within-host mechanisms of antibody production and persistence. Extended sampling and linking seroprevalence data to outcomes would allow for powerful conclusions about how humoral kinetics protect against disease.
Open AccessMechanistic models of humoral kinetics following COVID-19 vaccination
Introduction: Future COVID-19 vaccine programmes need to take into account the variable responses elicited by different vaccines and their waning protection over time. Existing descriptions of antibody response to COVID-19 vaccination convey limited information about the mechanisms of antibody production and maintenance. Methods: We describe the antibody dynamics elicited by COVID-19 vaccination with two biologically-motivated mathematical models of antibody production by plasma cells and subsequent decay. We fit the models using Markov Chain Monte Carlo to seroprevalence data from 14,602 uninfected individuals collected via the primary care network in England between May 2020 and September 2022. We ensure our models are structurally and practically identifiable when using antibody data alone. We analyse the effect of age, vaccine type, number of doses, and the interval between doses on antibody production and longevity of response. Results: We find evidence that individuals over 35 years of age who received a second dose of ChAdOx1-S generate a persistent antibody response suggestive of long-lived plasma cell induction, while individuals that receive two doses of BNT162b2, or one dose of either vaccine do not. We also find that plasamblast productive capacity, the likely driver of short-term antibody responses, is greater in younger people than older people (≤ 4.5 fold change in point estimates), people vaccinated with two doses than people vaccinated with one dose (≤ 12 fold change), and people vaccinated with BNT162b2 than people vaccinated with ChAdOx1-S (≤ 440 fold change). The effect of age on antibody dynamics is more pronounced in people vaccinated with BNT162b2 than people vaccinated with ChAdOx1-S. We find the half-life of an antibody to be between 23 – 106 days. Conclusion: Routinely-collected seroprevalence data are a valuable source of information for characterising within-host mechanisms of antibody production and persistence. Extended sampling and linking seroprevalence data to outcomes would allow for powerful conclusions about how humoral kinetics protect against disease.
- Open Access
- 15 March 2023
- Published by Springer Nature in Communications Medicine
- Vol. 3 (1) , 1-14
Evaluation and deployment of isotype-specific salivary antibody assays for detecting previous SARS-CoV-2 infection in children and adults
Background: Saliva is easily obtainable non-invasively and potentially suitable for detecting both current and previous SARS-CoV-2 infection, but there is limited evidence on the utility of salivary antibody testing for community surveillance. Methods: We established 6 ELISAs detecting IgA and IgG antibodies to whole SARS-CoV-2 spike protein, to its receptor binding domain region and to nucleocapsid protein in saliva. We evaluated diagnostic performance, and using paired saliva and serum samples, correlated mucosal and systemic antibody responses. The best-performing assays were field-tested in 20 household outbreaks. Results: We demonstrate in test accuracy (N = 320), spike IgG (ROC AUC: 95.0%, 92.8–97.3%) and spike IgA (ROC AUC: 89.9%, 86.5–93.2%) assays to discriminate best between pre-pandemic and post COVID-19 saliva samples. Specificity was 100% in younger age groups (0–19 years) for spike IgA and IgG. However, sensitivity was low for the best-performing assay (spike IgG: 50.6%, 39.8–61.4%). Using machine learning, diagnostic performance was improved when a combination of tests was used. As expected, salivary IgA was poorly correlated with serum, indicating an oral mucosal response whereas salivary IgG responses were predictive of those in serum. When deployed to household outbreaks, antibody responses were heterogeneous but remained a reliable indicator of recent infection. Intriguingly, unvaccinated children without confirmed infection showed evidence of exposure almost exclusively through specific IgA responses. Conclusions: Through robust standardisation, evaluation and field-testing, this work provides a platform for further studies investigating SARS-CoV-2 transmission and mucosal immunity with the potential for expanding salivo-surveillance to other respiratory infections in hard-to-reach settings.
- 15 March 2023
- Published by Springer Nature in Communications Medicine
- Vol. 3 (1) , 1-14
Open AccessEvaluation and deployment of isotype-specific salivary antibody assays for detecting previous SARS-CoV-2 infection in children and adults
Background: Saliva is easily obtainable non-invasively and potentially suitable for detecting both current and previous SARS-CoV-2 infection, but there is limited evidence on the utility of salivary antibody testing for community surveillance. Methods: We established 6 ELISAs detecting IgA and IgG antibodies to whole SARS-CoV-2 spike protein, to its receptor binding domain region and to nucleocapsid protein in saliva. We evaluated diagnostic performance, and using paired saliva and serum samples, correlated mucosal and systemic antibody responses. The best-performing assays were field-tested in 20 household outbreaks. Results: We demonstrate in test accuracy (N = 320), spike IgG (ROC AUC: 95.0%, 92.8–97.3%) and spike IgA (ROC AUC: 89.9%, 86.5–93.2%) assays to discriminate best between pre-pandemic and post COVID-19 saliva samples. Specificity was 100% in younger age groups (0–19 years) for spike IgA and IgG. However, sensitivity was low for the best-performing assay (spike IgG: 50.6%, 39.8–61.4%). Using machine learning, diagnostic performance was improved when a combination of tests was used. As expected, salivary IgA was poorly correlated with serum, indicating an oral mucosal response whereas salivary IgG responses were predictive of those in serum. When deployed to household outbreaks, antibody responses were heterogeneous but remained a reliable indicator of recent infection. Intriguingly, unvaccinated children without confirmed infection showed evidence of exposure almost exclusively through specific IgA responses. Conclusions: Through robust standardisation, evaluation and field-testing, this work provides a platform for further studies investigating SARS-CoV-2 transmission and mucosal immunity with the potential for expanding salivo-surveillance to other respiratory infections in hard-to-reach settings.